Warning over startling rise in younger men with prostate cancer: cases treble in last 22 years
Prostate cancer diagnoses among men under 50 in England have risen dramatically, with cases increasing from 158 in 2001 to 640 in 2023, representing a 305 per cent increase. This is a more pronounced rise than in other early-onset cancers, including bowel cancer, which has drawn less attention despite affecting younger people. The rising trend has prompted concerns among cancer researchers and campaigners alike, with leading figures including Jeremy Clarkson and Stephen Fry urging the government to establish a national prostate cancer screening programme.
The rate increased from one case per 100,000 men under 50 in 2001 to 3.6 per 100,000 by 2023. Experts attribute the rise to multiple factors: increased awareness and testing, alongside lifestyle changes such as rising obesity rates and diets high in processed meat, particularly nitrate and nitrite-containing products. However, Professor Prabhakar Rajan of Queen Mary University notes that higher diagnoses do not necessarily indicate younger men are more likely to develop the disease – the increase could partly reflect better detection and awareness rather than genuine increases in incidence. The analysis also revealed steep rises in bowel cancer (from 1,289 to 2,989 cases annually), kidney cancer (from 510 to 1,065) and womb cancer (from 335 to 698).
- Prostate cancer cases in men under 50 rose from 158 to 640 annually over 22 years
- Obesity, processed meat consumption and increased testing may be contributing factors
- Experts warn the increase doesn't necessarily mean more men developing the disease
New here? Start with this
Prostate cancer is a cancer that develops in the prostate gland, which is part of the male reproductive system. In recent years, diagnoses of this disease have increased considerably among younger men in England. This rise has caught the attention of health experts and raised questions about what might be driving the trend.
Several factors could explain why more younger men are receiving a prostate cancer diagnosis. Increased awareness, better testing practices, and lifestyle changes such as rising obesity rates have all been cited as possible contributors. Some experts suggest that improved detection methods may account for part of the increase, meaning the disease may not actually be becoming more common in younger men – the rise could reflect cases being identified that would previously have gone undetected.
This trend is not unique to prostate cancer. Other cancers including bowel, kidney, and womb cancer have also shown rises in younger people, suggesting a broader pattern worth investigating. The question of whether more screening should be encouraged remains a topic of debate among health professionals and campaigners.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Advocates for a national prostate cancer screening programme cite the tripling of diagnoses among younger men as evidence of a serious emerging public health threat requiring coordinated action. They argue that early detection through structured screening improves outcomes and saves lives, whilst ensuring equitable access across all populations, reflecting a commitment to prevention where evidence suggests intervention helps.
The case against
Critics contend that increased diagnoses may largely reflect improved detection and awareness rather than genuine rises in disease incidence among younger men, as experts have noted. They argue that a national screening programme risks substantial harms—false positives, overdiagnosis of slow-growing tumours unlikely to cause serious harm, unnecessary treatment and anxiety—and maintains that resources should be better directed towards understanding true disease drivers and targeting intervention to those most likely to benefit.